Warm Autoimmune Hemolytic Anemia Clinical Trial
Official title:
An Open Label, Prospective, Study to Assess the Safety, Tolerability, Efficacy and Pharmacokinetics of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD)
This study is to assess the safety, tolerability, preliminary efficacy, and pharmacokinetics of APL-2 in subjects with warm Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05786573 -
A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)
|
Phase 3 | |
| Withdrawn |
NCT03965624 -
Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune Cytopenia
|
Phase 2 | |
| Recruiting |
NCT05922839 -
Zanubrutinib in the Treatment of Relapsed/Refractory wAIHA
|
Phase 2 | |
| Completed |
NCT01181154 -
Rituximab in Auto-Immune Hemolytic Anemia
|
Phase 3 | |
| Recruiting |
NCT05925023 -
Sirolimus in the Treatment of Refractory/Relapsed wAIHA
|
Phase 2 | |
| Recruiting |
NCT05757570 -
An Open-label Study of Povetacicept in Subjects With Autoimmune Cytopenias
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT04256148 -
ALXN1830 in Patients With Warm Autoimmune Hemolytic Anemia
|
Phase 2 | |
| Terminated |
NCT03075878 -
A Safety Study of SYNT001 in Participants With Warm Autoimmune Hemolytic Anemia (WAIHA)
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT04956276 -
Subcutaneous ALXN1830 in Adult Participants With Warm Autoimmune Hemolytic Anemia
|
Phase 2 | |
| Recruiting |
NCT04119050 -
Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia
|
Phase 2/Phase 3 | |
| Terminated |
NCT04253236 -
To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAIHA).
|
Phase 2 | |
| Temporarily not available |
NCT05221619 -
Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)
|